Archive for June 2018

Paris, France and Cambridge, MA, USA – June 20, 2018  ENTEROME SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces that Dr Christophe Bonny, Chief Scientific Officer and Rodolphe Clerval, Chief Business Officer will... read more →

Paris, France and Cambridge, MA, USA – June 4, 2018  ENTEROME SA, a clinical-stage biotechnology company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, will attend the Jefferies 2018 Global Healthcare Conference. The conference will be held in New... read more →

Paris, France and Cambridge, MA, USA – June 1, 2018  ENTEROME SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces it will, for the first time, present promising Phase 1 clinical data with its lead... read more →